Treatment for relapse in stage I/II Hodgkin's lymphoma after initial single-modality treatment

Clinical Lymphoma and Myeloma

Volumn 6, Issue 5, 2006, Pages 389-392

  Rueda, Antonio ^a   Olmos Hidalgo, David ^a   Viciana, Ruth ^a   Alba, Emilio ^a  

^a HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

Author keywords

Autologous hematopoietic stem cell transplantation; Salvage therapy; Supradiaphragmatic disease

Indexed keywords

BLEOMYCIN; CARMUSTINE; CISPLATIN; CYTARABINE; DACARBAZINE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; MELPHALAN; METHYLPREDNISOLONE SODIUM SUCCINATE; VINBLASTINE;

ADOLESCENT; ADULT; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CANCER COMBINATION CHEMOTHERAPY; CANCER LOCALIZATION; CANCER MORTALITY; CANCER RELAPSE; CANCER STAGING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG MEGADOSE; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FOLLOW UP; HODGKIN DISEASE; HUMAN; LYMPH NODE METASTASIS; MALE; MANTLE FIELD RADIOTHERAPY; MONOTHERAPY; SALVAGE THERAPY; SYMPTOMATOLOGY; TREATMENT OUTCOME; TREATMENT RESPONSE;

EID: 33646542700     PISSN: 15579190     EISSN: None     Source Type: Journal    
DOI: 10.3816/CLM.2006.n.015     Document Type: Article

References (18)

1. Straus DJ, Portlock CS, Qin J, et al. Results of a prospective randomized clinical trial of doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) followed by radiation therapy (RT) versus ABVD alone for stages I, II, and IIIA nonbulky Hodgkin disease. Blood 2004; 104:3483-3489.
2. Meyer RG, Gospodarowicz M, Connors M, et al. A randomised phase III comparison of single-modality ABVD with a strategy that includes radiation therapy in patients with early-stage non-Hodgkin's disease: the HD-6 trial of National Cancer Institute of Canada Clinical Trials Group (Eastern Cooperative Oncology Group trial JHD06). Blood 2003; 102:26a (Abstract #81).
3. Longo DL. Hodgkin disease: the sword of Damocles resheathed. Blood 2004; 104:3418.
4. Cimino G, Biti GP, Carroni C, et al. Chemotherapy versus radiotherapy in early-stage Hodgkin's disease: evidence of a more difficult rescue for patients relapsed after chemotherapy. Eur J Cancer 1992; 28a: 1853-1855.
5. Rueda A, Alba E, Ribelles N, et al. Six cycles of ABVD in the treatment of stage I and II Hodgkin's lymphoma: a pilot study. J Clin Oncol 1997; 15:1118-1122.
6. Rueda Domínguez A, Márquez A, Gumá J, et al. Treatment of stage I and II Hodgkin's lymphoma with ABVD chemotheraphy: results after 7 years of a prospective study. Ann Oncol 2004; 15:1798-1804.
7. Lukes RJ, Butler JJ. The pathology and nomenclature of Hodgkin's disease. Cancer Res 1966; 26:1063-1083.
8. Lister TA, Crowther D, Sutcliffe SB, et al. Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting. J Clin Oncol 1989; 7:1630-1636.
9. Press OW, Livingston R, Mortimer J, et al. Treatment of relapsed non-Hodgkin's lymphomas with dexamethasone, high-dose cytarabine, and cisplatin before marrow transplantation. J Clin Oncol 1991; 9:423-431.
10. Velasquez WS, McLaughlin P, Tucker S, et al. ESHAP an effective chemotherapy regimen in refractory and relapsing lymphoma: a 4-year follow-up study. J Clin Oncol 1994; 12:1169-1176.
11. Linch DC, Winfield D, Goldstone AH, et al. Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomised trial. Lancet 1993; 341:1051-1054.
12. Josting A, Franklin J, May M, et al. New prognostic score based on outcome of patients with relapsed Hodgkin's lymphoma registered in the database of the German Hodgkin's Lymphoma Study Group. J Clin Oncol 2002; 20:221-230.
13. Wirth A, Corry J, Laidlaw C, et al. Salvage radiotherapy for Hodgkin's disease following chemotherapy failure. Int J Radiat Oncol Biol Phys 1997; 39:599-607.
14. Leigh BR, Fox KA, Mack CF, et al. Radiation therapy as Salvage of Hodgkin's disease following chemotherapy failure. Int J Radiat Oncol Biol Phys 1993; 27:855-862.
15. Pezner RD, Lipsett JA, Vora N, et al. Radical radiotherapy as salvage treatment for relapse of Hodgkin' disease initially treated by chemotherapy alone: prognostic significance of disease-free interval. Int J Radiat Oncol Biol Phys 1994; 30:965-970.
16. Brada M, Eeles R, Ashley S, et al. Salvage radiotherapy in recurrent Hodgkin's disease. Ann Oncol 1992; 3:131-135.
17. Josting A, Nogová L, Franklin J, et al. Salvage radiotherapy in patients with relapsed and refractory Hodgkin's lymphoma: a retrospective analysis from the German Hodgkin Lymphoma Study Group. J Clin Oncol 2005; 23:1522-1529.
18. Horwich A, Specht L, Ashley S. Survival analysis of patients with clinical stages I or II Hodgkin's disease who have relapsed after initial treatment with radiotherapy alone. Eur J Cancer 1997; 16:848-853.